|
Journal of Child and Adolescent Psychopharmacology
Manic Symptoms and Behavioral Dysregulation in Youth with Velocardiofacial Syndrome (22q11.2 Deletion Syndrome)
To cite this article:
Alka Aneja, Wanda P. Fremont, Kevin M. Antshel, Stephen V. Faraone, Nuria AbdulSabur, Anne Marie Higgins, Robert Shprintzen, Wendy R. Kates.
Journal of Child and Adolescent Psychopharmacology.
February 2007,
17(1): 105-114.
doi:10.1089/cap.2006.0023.
Alka Aneja, M.D.Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York. Wanda P. Fremont, M.D.Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York. Kevin M. Antshel, Ph.D.Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York. Stephen V. Faraone, Ph.D.Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York. Nuria AbdulSabur, B.A.Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York. Anne Marie Higgins, N.P.Department of Otolaryngology, SUNY Upstate Medical University, Syracuse, New York. Robert Shprintzen, Ph.D.Department of Otolaryngology, SUNY Upstate Medical University, Syracuse, New York. Wendy R. Kates, Ph.D.Departments of Psychiatry and Behavioral Sciences, and Program in Neuroscience, SUNY Upstate Medical University, Syracuse, New York. Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland. Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk factor for the eventual development of bipolar disorder in this population. Therefore, we sought to determine whether children with VCFS exhibit more manic symptoms than community controls that also may have learning disorders and ADHD. The study population consisted of 86 children with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania Rating Scale–Parent Version, Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL), and Wechsler Intelligence Scale for Children–3rd edition (WISC-III). The results indicate that manic symptoms were not more prevalent in VCFS than in a community sample of children with learning disorders and ADHD. However, after accounting for symptoms of depression and ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Behavior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct problems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only. Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic symptoms suggest that these children may warrant more intensive monitoring and treatment relative to youth with VCFS and ADHD only.  This paper was cited by:Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome) Edith M. Jolin, Ronald A. Weller, Elizabeth B. Weller Current Psychiatry Reports. May 2009, Vol. 11, No. 2: 99-105 CrossRef Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia J. S. Brown Schizophrenia Bulletin. Feb 2009, Vol. 35, No. 1: 256-278 CrossRef Schizophrenia and 22q11.2 deletion syndrome Anne S. Bassett, Eva W.C. Chow Current Psychiatry Reports. May 2008, Vol. 10, No. 2: 148-157 CrossRef Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome Doron Gothelf, Marie Schaer, Stephan Eliez Developmental Disabilities Research Reviews. Feb 2008, Vol. 14, No. 1: 59-68 CrossRef
|
|